Phase 2 Trial of Stem Cell Therapy in Parkinson’s Patients Enrolling

Phase 2 Trial of Stem Cell Therapy in Parkinson’s Patients Enrolling

292536

Phase 2 Trial of Stem Cell Therapy in Parkinson’s Patients Enrolling

A newly opened Phase 2 clinical trial is evaluating adult stem cells as a potentially disease-modifying treatment for Parkinson’s, building on an earlier study, thought to be the first of its kind, that found a single infusion of these cells safe and well tolerated by patients. This study will use mesenchymal stem cells, which are found in the bone marrow. These cells are important for making and repairing tissue like cartilage and bone, and may prevent the…

You must be logged in to read/download the full post.